-
digital.ahrq.gov/sites/default/files/docs/quality-metrics-slides-042811.pdf
January 01, 2011 - on individual patients not
receiving essential medications
UPQUAL Targets
• CHD
Antiplatelet therapy … Physician Sees Patient Who Needs
Testing or Treatment
•Simple
•No need to read
•All pre-checked … • Physicians asked to review charts and either
document exception or contact patient to
initiate therapy … Board
certification
– Satisfaction measures – patients’ perception of the relative benefits of
treatment … on quality and quantity of life balanced by the difficulty of
undergoing the necessary treatment
–
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs018648-atlas-final-report-2014.pdf
January 01, 2014 - However, national
and local data indicate that we are falling well short of treatment goals for these … Prior work done by
our group demonstrated that PCPs were willing to start or change statin therapy … model of chronic disease medication management in which the
decision to initiate or adjust medical therapy … linked to a sequence of subsequent
clinical actions (e.g., monitoring for ADEs, assessing response to therapy … Laboratory testing options were to monitor treatment efficacy (LDL,
HbA1c) and/or treatment safety
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/abTWXPvJyAMcqN9KcEt-vt
September 06, 2016 - For each included study, one investigator extracted information
about design, population, tests or treatments … The combina-
tion therapy was found to be noninferior to isoniazid-only treat-
ment. … .94 A later study by the same authors (described above) ran-
domized 847 participants to the same 2 treatments … Limited usefulness of QuantiFERON-TB Gold
In-Tube for monitoring anti-tuberculosis therapy. … Adverse
events with 4 months of rifampin therapy or 9
months of isoniazid therapy for latent tuberculosis
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/wBcZfBcVp8N3-cyT3Peysv
April 01, 2016 - Panel III treatment guidelines) (66). … The 11 pri-
mary prevention studies are heterogeneous in terms of
aspirin dose; duration of therapy; … conclude
that the cardiovascular-related benefits (that is, nonfatal
MI) occur during the first 5 years of therapy … AHA/ACCF Secondary Prevention
and Risk Reduction Therapy for Patients with Coronary and other
Atherosclerotic … Primary and secondary prevention of cardiovascular disease: Anti-
thrombotic Therapy and Prevention of
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-in-nonpregnant-adults-and-adolescents-june-2016
June 07, 2016 - Benefits of Early Detection and Treatment
The USPSTF found convincing evidence that treatment with … headache, myalgia, and other symptoms), which may occur within the first 24 hours after any syphilis therapy … Sexually transmitted diseases treatment guidelines, 2015. … Epidemiologic treatment of contacts to infectious syphilis. … Therapy for incubating syphilis. Effectiveness of gonorrhea treatment.
-
effectivehealthcare.ahrq.gov/products/prostate-cancer-radiation/research
-
effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1412.pdf
December 01, 2014 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … Off-label intranasal oxytocin for treatment of autism
spectrum disorders
No high-impact potential … Presently, behavioral therapies and pharmaceutical treatments are
used to improve various symptoms … ES-3
Eligible Topic Not Deemed High Impact
Off-label intranasal oxytocin for treatment of autism
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_disposition-comments.pdf
May 01, 2013 - Are the same treatments known to be effective in
general population similarly effective among women … depression and
other outcomes without linking to screening; is there
strong evidence for effective treatments … While treatments for
postpartum depression are beyond the scope of
this review, we agree that questions … completed and when they are
completed, they are unlikely to lead to engagement
with evidence-based treatments … cannot be effective.
4) We have revised the report to indicate that
there are a range of potential treatments
-
psnet.ahrq.gov/node/73643/psn-pdf
August 01, 2022 - psnet.ahrq.gov//mailto:ljunge-m@bidmc.harvard.edu
https://psnet.ahrq.gov//mailto:llipsitz@bidmc.harvard.edu
treatment … medication, omission of a medication), monitoring errors, and missed opportunities for
optimizing therapy
-
psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.127_slideshow.ppt
May 01, 2006 - The orthopedist failed to elicit or to discover the history of the patient's previous diagnosis or treatment … It simply indicates that an undesirable clinical outcome resulted from some aspect of diagnosis or therapy
-
psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.158_slideshow.ppt
September 01, 2007 - Transitions in Care
Multiple handoffs among health care providers
Numerous changes to the patient’s therapeutic … Influence of hospitalization on drug therapy in the elderly. … Patient-physician communication at hospital discharge and patients' understanding of the postdischarge treatment
-
psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.344_slideshow.ppt
April 01, 2015 - 1-23. http://www.ncbi.nlm.nih.gov/pubmed/24804329
*
Risk Management Pitfalls (2)
Thrombolytic therapy
-
psnet.ahrq.gov/web-mm/shake-well
September 01, 2006 - Daily serum drug levels consistently fell below the therapeutic range, which led the physicians to gradually … In addition, 6% of doses are not administered; if a patient is not responding to therapy, an omission
-
psnet.ahrq.gov/node/49447/psn-pdf
June 01, 2004 - The Commentary
Many well-known factors contributing to drug therapy mishaps or misadventures were likely
-
psnet.ahrq.gov/node/49727/psn-pdf
March 01, 2015 - reflect pathophysiological derangements at
such variance with normal as to be life threatening if therapy
-
psnet.ahrq.gov/node/49814/psn-pdf
December 01, 2017 - months previously, he had experienced a myocardial infarction
and was started on dual antiplatelet therapy … Fortunately, the patient did not experience bleeding, a potential and sometimes devastating
complication of therapeutic
-
www.ahrq.gov/sites/default/files/wysiwyg/sops/events/webinar/03-sops-riverside-handoffs-webcast-hansford.pdf
January 01, 2023 - Palliative Care,
Hospice Care
Mem ory Care,
Ca re giver
Support,
Research, &
Education
Physical
Therapy
-
hcup-us.ahrq.gov/db/vars/disp/nisnote.jsp
September 01, 2008 - For all years, the source disposition "Discharged to home under the care of a Home IV Drug Therapy provider
-
psnet.ahrq.gov/web-mm/secured-not-always-safe
October 01, 2015 - Following surgical drainage and continued antibiotic therapy, the patient improved clinically and was
-
digital.ahrq.gov/sites/default/files/docs/page/reduction-in-hospital-acquired-complications-and-infections-quick-reference-guide.pdf
January 01, 2010 - Prevention
of venous thromboembolism: the Seventh ACCP
Conference on Antithrombotic and Thrombolytic
Therapy